The molecular targets for the diagnosis and treatment of pancreatic cancer.
Pancreatic cancer is considered an aggressive malignancy that responds poorly to current treatments and therefore has a dismal survival rate. This disease is usually not diagnosed until a late stage, at which point palliative chemotherapy with the purine analogue gemcitabine and/or a fluoropyrimidine or a platinum agent is the standard approach. There are some new data on the molecular and genetic changes that take place in pancreatic cancer, which may facilitate the accuracy of diagnosis and efficacy of treatments. However, translational efforts in clinical practice have increased clinicians' options with a targeted agent, erlotinib, in combination with the standard gemcitabine chemotherapy. Many other novel drugs currently being tested in the field of pharmaco-oncology target various altered biological pathways and molecules. Nevertheless, the lack of clinically significant improvements in treatments is rendering efforts to develop methods of early diagnosis both more urgent and promising. The aim of this review was to summarize the molecular basis of pancreatic carcinogenesis and the latest developments in diagnosis by molecular means, focusing on the results of clinical research into targeted and personalized treatments.
Oncology Unit, 3rd Department of Medicine, Sotiria General Hospital, Athens, Greece.
Alexios S
AS
Strimpakos
Kostas N
KN
Syrigos
Muhammad Wasif
MW
Saif
Gastroenterology. 1995 May;108(5):1526-33
7537236
World J Gastroenterol. 2005 Apr 14;11(14):2162-5
15810085
Jpn J Cancer Res. 1995 Feb;86(2):174-81
7730141
J Clin Oncol. 2006 Nov 20;24(33):5313-27
17060676
Oncology. 2006;71(1-2):61-8
17377415
Am J Clin Oncol. 2011 Feb;34(1):50-2
24757739
Oncology. 2009;76(4):254-61
19246950
J Clin Oncol. 2009 Apr 10;27(11):1806-13
19273710
Dig Surg. 2006;23(1-2):74-9
16717472
Int J Oncol. 2004 Mar;24(3):679-85
14767553
Mol Cancer Ther. 2006 Mar;5(3):483-93
16546962
World J Surg. 2009 Apr;33(4):698-709
19030927
J Clin Pathol. 2006 Apr;59(4):382-6
16467169
JOP. 2008 Jul 10;9(4):398-402
18648129
Int J Cancer. 2007 Aug 1;121(3):656-65
17417771
Cancer Lett. 2006 Jun 8;237(1):143-54
16009488
Cancer Chemother Pharmacol. 2006 Dec;58(6):765-70
16552573
N Engl J Med. 2008 Oct 23;359(17):1757-65
18946061
Hepatobiliary Pancreat Dis Int. 2002 May;1(2):302-5
14612290
World J Gastroenterol. 2003 Dec;9(12):2764-7
14669329
Acta Pharmacol Sin. 2007 Aug;28(8):1224-30
17640486
Biochem Biophys Res Commun. 2006 Oct 6;348(4):1245-53
16904634
Am J Surg Pathol. 2001 May;25(5):579-86
11342768
Cancer Res. 2005 Jun 1;65(11):4870-80
15930308
Cancer Biol Ther. 2007 Mar;6(3):324-8
17404500
Cancer Res. 2005 Oct 1;65(19):9064-72
16204081
Ann Surg. 2005 Dec;242(6):791-800, discussion 800-1
16327489
Nucleic Acids Res. 1988 Aug 25;16(16):7773-82
3047672
J Cancer Res Clin Oncol. 2001 Jul;127(7):449-54
11469683
Int J Pancreatol. 1997 Apr;21(2):127-43
9209954
Oncology. 2006;71(3-4):159-63
17646699
J Clin Gastroenterol. 2010 Apr;44(4):286-8
20216081
Biochim Biophys Acta. 2004 Sep 17;1693(3):167-76
15363630
Anticancer Res. 2009 Aug;29(8):3173-8
19661331
Br J Cancer. 2003 Jul 21;89(2):391-7
12865934
J Natl Cancer Inst. 1998 Oct 21;90(20):1529-36
9790545
Mol Biosyst. 2010 Jan;6(1):44-54
20024066
J Clin Oncol. 2002 Dec 1;20(23):4531-42
12454109
J Clin Oncol. 2004 Jul 1;22(13):2610-6
15226328
Am J Clin Pathol. 2002 May;117(5):791-6
12090430
Jpn J Clin Oncol. 2004 May;34(5):238-44
15231857
Cancer Res. 2000 Jan 15;60(2):409-16
10667595
Cancer Res. 1997 Jun 1;57(11):2140-3
9187111
Proc Natl Acad Sci U S A. 1996 Apr 16;93(8):3636-41
8622988
Int J Cancer. 2006 Apr 15;118(8):1930-6
16284950
J Clin Oncol. 2007 May 20;25(15):1960-6
17452677
BMJ. 2006 Jun 3;332(7553):1302-8
16740558
Oncology. 2009;76(4):270-4
19258727
J Clin Pathol. 1984 Feb;37(2):218-22
6198342
Am J Gastroenterol. 1990 Apr;85(4):350-5
2183589
Int J Cancer. 2006 May 1;118(9):2337-43
16331623
Eur J Cancer. 2002 Nov;38(17):2272-8
12441264
Cancer Res. 2010 Jul 1;70(13):5226-37
20551052
Cancer Res. 1998 Nov 1;58(21):4947-56
9810004
J Surg Oncol. 2000 Feb;73(2):95-9
10694645
Invest New Drugs. 2005 Oct;23(5):485-7
16133800
Proc Natl Acad Sci U S A. 2000 Aug 15;97(17):9624-9
10944227
Transl Oncol. 2010 Apr;3(2):109-13
20360935
Int J Oncol. 1998 May;12(5):1111-6
9538137
Antioxid Redox Signal. 2008 Mar;10(3):511-45
18370854
Cancer Res. 1999 Aug 1;59(15):3581-7
10446965
Cancer Res. 2004 Mar 15;64(6):2030-8
15026340
Pathol Res Pract. 2004;200(5):389-96
15239347
Cancer Res. 2007 Apr 15;67(8):3853-61
17440100
Cancer. 2006 Jun 1;106(11):2503-13
16628653
Mol Cancer Ther. 2005 Dec;4(12):1943-51
16373709
Proc Natl Acad Sci U S A. 2010 Jan 5;107(1):246-51
20018721
Biochem Biophys Res Commun. 2005 May 27;331(1):295-302
15845392
Clin Cancer Res. 2005 Dec 15;11(24 Pt 1):8773-81
16361565
Mol Cancer Res. 2007 Apr;5(4):309-20
17406026
J Clin Oncol. 2009 Nov 20;27(33):5499-505
19858399
J Clin Oncol. 2004 Dec 1;22(23):4737-45
15570074
Mol Cancer Ther. 2008 Sep;7(9):2725-35
18790753
Hum Pathol. 1993 Oct;24(10):1127-34
8104858
Am J Clin Pathol. 2002 May;117(5):755-65
12090425
Am J Cardiol. 2007 Jan 1;99(1):91-8
17196469
Proc Natl Acad Sci U S A. 2007 Mar 20;104(12):5103-8
17372229
Clin Cancer Res. 2008 Jul 15;14(14):4491-9
18628464
Br J Cancer. 2002 Jul 15;87(2):161-7
12107836
Ann Surg. 2002 Jan;235(1):51-9
11753042
Cell. 1993 Sep 24;74(6):957-67
8402885
Am J Clin Oncol. 2008 Apr;31(2):157-62
18391600
Cancer Res. 1997 May 1;57(9):1731-4
9135016
Cancer Epidemiol Biomarkers Prev. 2007 Feb;16(2):342-6
17301269
Mol Cancer Ther. 2002 Aug;1(10):777-83
12492110
Nature. 2003 Oct 23;425(6960):851-6
14520413
Cancer Lett. 2009 Jan 18;273(2):266-72
19004543
J Clin Oncol. 2004 Apr 15;22(8):1430-8
15084616
Anticancer Res. 2009 May;29(5):1803-10
19443408
Cancer Res. 2005 Aug 1;65(15):6934-42
16061678
Mol Carcinog. 2006 Jun;45(6):409-15
16652354
Cell. 1988 May 20;53(4):549-54
2453289
Br J Cancer. 2007 Apr 23;96(8):1166-9
17375050
Pancreas. 1997 Apr;14(3):229-36
9094152
Cancer Res. 2006 Nov 1;66(21):10553-9
17079479
Cancer Invest. 2004;22(5):706-12
15581051
J Clin Oncol. 2001 Aug 1;19(15):3447-55
11481349
Gut. 2002 May;50(5):653-7
11950811
Cancer Res. 1996 Mar 1;56(5):1137-41
8640773
J Surg Res. 2001 May 15;97(2):123-30
11341787
Am J Clin Oncol. 2001 Oct;24(5):496-9
11586103
Cancer Res. 2006 Jul 15;66(14):7041-9
16849549
Clin Cancer Res. 2010 Mar 15;16(6):1781-9
20215540
J Hepatobiliary Pancreat Surg. 2002;9(3):328-41
12353144
Cancer Invest. 2008 Oct;26(8):784-93
18798073
Mol Cancer Ther. 2004 Nov;3(11):1421-6
15542781
Clin Cancer Res. 1999 Aug;5(8):2018-24
10473081
J Clin Oncol. 2009 Jan 10;27(2):193-8
19047305
Am J Pathol. 1993 Aug;143(2):545-54
8342602
J Clin Oncol. 2001 Feb 15;19(4):1167-75
11181683
Mol Cancer Ther. 2006 Nov;5(11):2676-84
17121914
Virchows Arch. 2006 Jun;448(6):797-804
16568310
J R Soc Med. 2006 Mar;99(3):132-40
16508052
J Natl Cancer Inst. 2003 Feb 5;95(3):214-21
12569143
J Clin Oncol. 2005 Aug 10;23(23):5281-93
16009947
Am J Clin Pathol. 2002 Aug;118(2):194-201
12162677
Cancer. 2004 Jul 1;101(1):133-8
15221998
Int J Cancer. 2000 Nov 20;89(6):469-74
11102889
Arch Pathol Lab Med. 2009 Mar;133(3):413-22
19260747
Biomed Pharmacother. 2005 Oct;59 Suppl 2:S276-80
16507392
Cancer Lett. 2010 Jun 1;292(1):8-16
20004512
J Clin Pathol. 2005 Aug;58(8):845-52
16049287
Cancer Res. 2004 Jan 15;64(2):622-30
14744777
Anticancer Drugs. 2007 Jun;18(5):569-79
17414626
Cancer Res. 2002 Jul 1;62(13):3789-93
12097290
Pancreatology. 2005;5(4-5):361-9
15980665
Clin Cancer Res. 2007 Jul 1;13(13):3913-21
17606725
J Clin Oncol. 2003 Apr 1;21(7):1301-6
12663718
J Clin Oncol. 2003 Sep 1;21(17):3296-302
12947065
Mol Carcinog. 2003 Oct;38(2):59-69
14502645
Invest New Drugs. 2005 Dec;23(6):583-90
16034525
Surg Clin North Am. 1995 Oct;75(5):845-55
7660249
Anticancer Res. 2001 Mar-Apr;21(2A):1043-8
11396138
Curr Opin Oncol. 1995 Nov;7(6):547-53
8547404
Hepatogastroenterology. 2005 Mar-Apr;52(62):398-403
15816444
J Hepatobiliary Pancreat Surg. 2007;14(3):243-54
17520199
Clin Cancer Res. 2001 Dec;7(12):4115-21
11751510
Clin Cancer Res. 1997 Sep;3(9):1473-7
9815833
Cancer Res. 2006 Mar 1;66(5):2778-84
16510599
J Clin Oncol. 2004 Nov 15;22(22):4456-62
15483017
Cancer Res. 1996 Dec 1;56(23):5360-4
8968085
Cancer Biol Ther. 2004 Dec;3(12):1217-24
15477758
Eur J Cancer. 2005 Oct;41(15):2213-36
16146690
Br J Cancer. 1991 Dec;64(6):1076-82
1764370
Ann Surg Oncol. 2006 Jul;13(7):933-9
16788754
Clin Cancer Res. 2005 Aug 1;11(15):5356-64
16061848
Pharmacoepidemiol Drug Saf. 2007 Jul;16(7):762-72
17457957
Clin Cancer Res. 1997 Aug;3(8):1309-16
9815813
J Surg Oncol. 2003 Feb;82(2):111-20
12561067
Cancer Res. 1996 Jun 1;56(11):2527-30
8653691
Biochem Biophys Res Commun. 2003 Jul 11;306(4):799-804
12821112
Gastroenterology. 2009 Sep;137(3):1102-13
19501590
J Gastrointest Surg. 2005 Sep-Oct;9(7):903-11
16137582
PLoS One. 2010 Apr 26;5(4):e10347
20436683
J Surg Oncol. 2007 Mar 15;95(4):332-6
17230496
Int J Gastrointest Cancer. 2005;35(1):33-41
15722572
JOP. 2006 May 09;7(3):283-94
16685109
Cancer Res. 2000 Apr 1;60(7):2002-6
10766191
Cancer Res. 1997 Aug 1;57(15):3126-30
9242437
Cell. 2000 Oct 13;103(2):295-309
11057902
Clin Cancer Res. 2007 Jan 1;13(1):18-26
17200334
Prostaglandins Leukot Essent Fatty Acids. 2006 Dec;75(6):429-34
17034997
Clin Cancer Res. 2008 Oct 1;14(19):5995-6004
18829478
Biochim Biophys Acta. 2007 Jul;1773(7):1095-106
17555830
Clin Cancer Res. 2001 Dec;7(12):4033-40
11751498